text: Biogen, Elan up on MS drug approval SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in premarket trade Wednesday after the US Food and Drug Administration approved the companies #39; multiple sclerosis drug Tysabri.